Study shows life-saving benefit of baricitinib for ventilated COVID patients

Feb. 7, 2022—Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

Read more